Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines

Medicine & Life Sciences

• Inflammatory Bowel Disease 2 100%
• Inactivated Vaccines 72%
• Gastroenterology 65%
• Practice Guidelines 54%
• Immunization 49%
• Inflammatory Bowel Diseases 29%
• Vaccines 13%
• Vaccine-Preventable Diseases 12%
• Haemophilus influenzae type b 11%
• Hepatitis B Vaccines 11%
• Human Influenza 8%
• Immunosuppressive Agents 7%
• Vaccination 7%
• Herpes Zoster Vaccine 6%
• Haemophilus Vaccines 6%
• Meningococcal Vaccines 6%
• Active Immunotherapy 5%
• Diphtheria 5%
• Papillomavirus Vaccines 5%
• Pneumococcal Vaccines 5%
• Synthetic Vaccines 5%
• Neisseria meningitidis 5%
• Whooping Cough 5%
• Tetanus 5%
• Safety 5%
• Herpes Zoster 5%
• Advisory Committees 4%
• Centers for Disease Control and Prevention (U.S.) 4%
• Streptococcus pneumoniae 4%
• Contraindications 4%
• Biological Products 4%
• Hepatitis B 4%
• Canada 4%
• Young Adult 3%
• Population 3%
• Systematic Reviews 3%
• Pediatrics 2%
• Mortality 2%
• Therapeutics 0%